Guelph, Ontario-based Zentek Ltd. (Nasdaq: ZTEK, TSXV: ZEN) announced that Ilse Treurnicht stepped down from its board of directors. The resignation is effective immediately.
Treurnicht will transition to a role on Zentek‘s advisory board, continuing to support the company in a consulting capacity. Board Chair Eric Wallman noted her significant contributions to the board’s development over the past several years.
Following Treurnicht‘s departure, John Snisarenko assumed the role of company secretary and chair of the corporate governance, compensation, and nominating committee. These were previously held by Treurnicht.
Additionally, Lisa Sim will not seek re-election to the board at the upcoming annual and special shareholder meeting on September 25, 2025. Similar to Treurnicht, Sim will join the advisory board, focusing on managing and advising on the company’s intellectual property portfolio.
Zentek is currently reviewing several shareholder-nominated candidates to fill the upcoming board vacancies. The company will finalize its selection process shortly.
Due to these changes, Zentek will revise and resend its proxy voting materials for the September 25th meeting. A separate press release will provide details on the updated nominee list and voting instructions.
Zentek Ltd. is an ISO 13485:2016-certified intellectual property technology company. The company focuses on the research, development, and commercialization of innovative products designed to enhance the competitiveness of its commercial partners by improving product quality, safety, and environmental impact.
Its patented ZenGUARD™ technology enhances viral filtration in surgical masks and HVAC systems. The ZenGUARD™ production facility is located in Guelph, Ontario. The company also holds a global exclusive license for aptamer-based platform technology developed by McMaster University, which is being jointly developed for diagnostic and therapeutic applications.
The company’s statement included standard forward-looking statements, noting inherent risks and uncertainties associated with future events and conditions. Zentek disclaims any obligation to update or revise any forward-looking statements unless required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the accuracy or adequacy of this release.
Related
